Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-03-09 @ 12:19 AM
Study NCT ID:
NCT02552160
Status:
COMPLETED
Last Update Posted:
2018-12-11
First Post:
2015-07-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Obstructive Pulmonary Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Chronic Obstructive Pulmonary Disease | View |
| None | Fixed-dose Combination | View |
| None | LAMA/LABA (Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists) | View |
| None | Inhaler | View |
| None | Aclidinium/Formoterol | View |
| None | Glycopyrronium/Indacaterol | View |
| None | Umeclidinium/Vilanterol | View |